RxDoctor Payments Data

Heidi Curtis

Family · Grimes, IANPI 1578958542

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 435 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 29.4% of the total. 2025 is the largest year on record at $2,414, 3.5 times the $689 reported in 2021. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,782in general payments, 2019–2025

Across 435 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Sun Pharmaceutical Industries Inc.$835
  • Lilly USA, LLC$473
  • UCB, Inc.$392
  • Pfizer$266
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$6,24892%
  • Education$5348%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,782 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.

See all family providers in Iowa

Medicare billing

Part B allowed, 2024
$204,581
Medicare patients
444
Services billed
3,078

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab18$123,687
Dupixent PenDupilumab25$108,729
Clobetasol Propionate94$3,624
Tretinoin31$2,745
Metronidazole25$1,381
Fluocinonide26$1,347
Fluorouracil18$1,225
Pimecrolimus11$1,150
Doxycycline Monohydrate49$1,004
Ciclopirox31$910
Ketoconazole72$848
Triamcinolone Acetonide76$644
Clindamycin Phosphate15$553
Betamethasone Dipropionate13$551
Mupirocin37$243

Paid to pharmacies, not to this prescriber.

Other family in Grimes

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →